MedPath

Wenzhou Medical University

🇨🇳China
Ownership
-
Established
1958-01-01
Employees
-
Market Cap
-
Website
http://www.WZMC.edu.cn/

Clinical Trials

94

Active:4
Completed:39

Trial Phases

5 Phases

Phase 1:2
Phase 2:3
Phase 3:3
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (53 trials with phase data)• Click on a phase to view related trials

Not Applicable
43 (81.1%)
Phase 2
3 (5.7%)
Phase 3
3 (5.7%)
Phase 1
2 (3.8%)
Phase 4
2 (3.8%)

Comparing Monofocal IOLs in Highly Myopic Cataract Patients

Not yet recruiting
Conditions
Cataract
First Posted Date
2025-04-02
Last Posted Date
2025-04-02
Lead Sponsor
Wenzhou Medical University
Target Recruit Count
60
Registration Number
NCT06905938
Locations
🇨🇳

Ophthalmology and Optometry Hos, Hanzhou, zhejian, China

Visual Quality of Cataract Patients with High Myopia After Implantation of Different Intraocular Lenses

Active, not recruiting
Conditions
Cataract
First Posted Date
2025-03-24
Last Posted Date
2025-03-24
Lead Sponsor
Wenzhou Medical University
Target Recruit Count
62
Registration Number
NCT06892470
Locations
🇨🇳

Ophthalmology and Optometry Hos, Hanzhou, zhejian, China

Using Psychophysics Methods to Investigate Sensory Dominance After Cataract Surgery

Active, not recruiting
Conditions
Cataract
First Posted Date
2024-12-27
Last Posted Date
2024-12-27
Lead Sponsor
Wenzhou Medical University
Target Recruit Count
96
Registration Number
NCT06751342
Locations
🇨🇳

Ophthalmology and Optometry Hospital, Wenzhou, Wenzhou, Zhejiang, China

Comparison of the Effect of Capsular Bend on the Rotational Stability Between Two Toric Intraocular Lenses

Active, not recruiting
Conditions
Cataract
First Posted Date
2024-11-27
Last Posted Date
2024-11-27
Lead Sponsor
Wenzhou Medical University
Target Recruit Count
68
Registration Number
NCT06707740
Locations
🇨🇳

Ophthalmology and Optometry Hospital, Wenzhou, Wenzhou, China

Quantitative Assessment of Lid Margin Vascularity Using SS-OCTA

Not yet recruiting
Conditions
Lid Margin Blood Flow Density
Ss-octa
MGD
First Posted Date
2023-10-19
Last Posted Date
2023-10-19
Lead Sponsor
Wenzhou Medical University
Target Recruit Count
150
Registration Number
NCT06091722
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 19
  • Next

News

FDA Grants Orphan Drug Designation to China-Developed ApDC for Uveal Melanoma

An Aptamer Drug Conjugate (ApDC) developed by Chinese researchers has received orphan drug designation from the FDA for uveal melanoma treatment.

© Copyright 2025. All Rights Reserved by MedPath